
CJC-1295 (No DAC)
Growth hormone releasing hormone analog studied for pulsatile GH release.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
About CJC-1295 (No DAC)
CJC-1295 without DAC (also sold as Modified GRF 1-29) is a 30-piece copy of GHRH, the natural signal that tells the pituitary gland to release growth hormone. Four small changes were made so enzymes can't chew it up as quickly.
It is a standard tool for studying natural growth hormone pulses, the GH/IGF-1 system, and how it works alongside peptides like Ipamorelin. Supplied as a freeze-dried research powder at 99%+ purity for laboratory use only.
What animal studies have reported
These are outcomes published in peer-reviewed animal (preclinical) research on CJC-1295 (No DAC). They describe results seen in laboratory animals only.
- Sustained rises in growth hormone and IGF-1 in rodent and dog studies
- Increased lean tissue growth in young animals
Animal findings do not predict results in humans. Nothing here is a claim about human use — this product is sold for laboratory research only.
Compound classification
Synthetic 30-amino-acid GHRH analog (Mod GRF 1-29) without the Drug Affinity Complex (DAC).
Mechanism studied in the literature
Binds GHRH receptors on pituitary somatotrophs; studied for short-acting pulsatile GH release in preclinical models, frequently paired with GHRPs in receptor research.
Research areas
- GHRH receptor pharmacology
- Pulsatile somatotroph signaling research
- GH/IGF-1 axis preclinical models
- Receptor desensitization studies
Storage
Lyophilized: -20°C, protected from light. Reconstituted: 2-8°C, use within 28 days.
Reconstitution (laboratory)
Reconstitute with bacteriostatic or sterile water for injection (USP grade).
Related research peptides

Ipamorelin
Selective GHRP studied for GH secretion without significant cortisol or prolactin impact.

GHRP-6
Growth hormone releasing peptide studied for GH secretion and appetite research.

Tesamorelin
GHRH analog researched for visceral adiposity and lipid metabolism.

Kisspeptin
Hypothalamic peptide studied for GnRH regulation and reproductive endocrinology.
